Cannabinoids: therapeutic use in clinical practice
Medical case reports suggest that cannabinoids extracted from Cannabis sativa have
therapeutic effects; however, the therapeutic employment is limited due to the psychotropic …
therapeutic effects; however, the therapeutic employment is limited due to the psychotropic …
Alzheimer's and Parkinson's disease therapies in the clinic
P Chopade, N Chopade, Z Zhao… - Bioengineering & …, 2023 - Wiley Online Library
Alzheimer's disease (AD) and Parkinson's disease (PD) are the most prevalent
neurodegenerative diseases, affecting millions and costing billions each year in the United …
neurodegenerative diseases, affecting millions and costing billions each year in the United …
The endocannabinoid system–current implications for drug development
CJ Fowler - Journal of internal medicine, 2021 - Wiley Online Library
In this review, the state of the art for compounds affecting the endocannabinoid (eCB)
system is described with a focus on the treatment of pain. Amongst directly acting CB …
system is described with a focus on the treatment of pain. Amongst directly acting CB …
Advances in the treatment and management of frontotemporal dementia
Introduction Frontotemporal dementia (FTD) is a complex neurodegenerative disorder,
characterized by a wide range of pathological conditions associated with the buildup of …
characterized by a wide range of pathological conditions associated with the buildup of …
Inhibition of human recombinant T‐type calcium channels by phytocannabinoids in vitro
S Mirlohi, C Bladen, MJ Santiago… - British Journal of …, 2022 - Wiley Online Library
Background and Purpose T‐type Ca channels (ICa) regulate neuronal excitability and
contribute to neurotransmitter release. The phytocannabinoids Δ9‐tetrahydrocannabinol …
contribute to neurotransmitter release. The phytocannabinoids Δ9‐tetrahydrocannabinol …
[HTML][HTML] Substance use and substance use disorders in Africa: An epidemiological approach to the review of existing literature
OJ Onaolapo, AT Olofinnade, FO Ojo… - World journal of …, 2022 - ncbi.nlm.nih.gov
The relationship between man and substances that have abuse potentials, and whose use
has been associated with the development or progression of substance use disorders has …
has been associated with the development or progression of substance use disorders has …
Discovery of a biased allosteric modulator for cannabinoid 1 receptor: preclinical anti-glaucoma efficacy
S Garai, LM Leo, AM Szczesniak… - Journal of Medicinal …, 2021 - ACS Publications
We apply the magic methyl effect to improve the potency/efficacy of GAT211, the prototypic 2-
phenylindole-based cannabinoid type-1 receptor (CB1R) agonist-positive allosteric …
phenylindole-based cannabinoid type-1 receptor (CB1R) agonist-positive allosteric …
OCP002, a mixed agonist of opioid and cannabinoid receptors, produces potent antinociception with minimized side effects
B Xu, Q Zhang, D Chen, M Zhang, R Zhang… - Anesthesia & …, 2023 - journals.lww.com
BACKGROUND: Increasing attention has been attracted to the development of bifunctional
compounds to minimize the side effects of opioid analgesics. Pharmacological studies have …
compounds to minimize the side effects of opioid analgesics. Pharmacological studies have …
The therapeutic potential of the endocannabinoid system in age-related diseases
The endocannabinoid system (ECS) dynamically regulates many aspects of mammalian
physiology. ECS has gained substantial interest since growing evidence suggests that it …
physiology. ECS has gained substantial interest since growing evidence suggests that it …
Endocannabinoid-binding receptors as drug targets
M Gómez-Cañas, C Rodríguez-Cueto, V Satta… - … Signaling: Methods and …, 2022 - Springer
Cannabis plant has been used from ancient times with therapeutic purposes for treating
human pathologies, but the identification of the cellular and molecular mechanisms …
human pathologies, but the identification of the cellular and molecular mechanisms …